Oral Tube Feeding for Sleep Quality in Stroke-related Dysphagia
Intermittent Oral-esophageal Tube Feeding
+ comprehensive rehabilitation therapy
+ Nasogastric Tube Feeding
Deglutition Disorders+3
+ Digestive System Diseases
+ Esophageal Diseases
Prevention Study
Summary
Study start date: November 30, 2024
Actual date on which the first participant was enrolled.This study focuses on improving sleep quality for patients who have trouble swallowing after a stroke, a condition known as dysphagia. While nasogastric tube feeding is commonly used to help with nutrition in these patients, it has certain drawbacks that need addressing. The research looks into whether a different method, called intermittent oro-esophageal tube feeding, can provide better results. By examining this new approach, the study aims to offer a potential solution that could enhance patient care and tackle ongoing challenges in managing stroke-related dysphagia. Participants in the study are stroke patients who have difficulty swallowing. They are randomly assigned to one of two groups: one group receives the new feeding method, the intermittent oro-esophageal tube feeding, while the other group continues with the traditional nasogastric tube feeding. Each participant is monitored over 15 days, during which their sleep quality is assessed at the beginning and end of the study. By comparing the sleep quality between the two groups, researchers hope to determine which feeding method might be more effective in improving rest for these patients. This study does not specifically mention risks or benefits, but it is designed to find a better way to support nutrition and sleep for those who need it.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.140 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives